BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11535210)

  • 1. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases.
    Tang OS; Thong KJ; Baird DT
    Contraception; 2001 Jul; 64(1):29-32. PubMed ID: 11535210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
    Gemzell-Danielsson K; Ostlund E
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):702-6. PubMed ID: 10949238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Thong KJ; Lynch P; Baird DT
    Contraception; 1996 Aug; 54(2):97-100. PubMed ID: 8842586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester.
    Thong KJ; Baird DT
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):191-6. PubMed ID: 1317641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Bartley J; Baird DT
    BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE; Thong KJ; Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C; Olund A
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis.
    Di Carlo C; Savoia F; Morra I; Ferrara C; Sglavo G; Nappi C
    Gynecol Endocrinol; 2014 Aug; 30(8):605-7. PubMed ID: 24905726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial.
    World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation
    Acta Obstet Gynecol Scand; 2001 May; 80(5):447-51. PubMed ID: 11328223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
    Bartley J; Brown A; Elton R; Baird DT
    Hum Reprod; 2001 Oct; 16(10):2098-102. PubMed ID: 11574498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost.
    Prasad RN; Choolani M
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):20-3. PubMed ID: 8775244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.